SCHEMBL3489894

SCHEMBL3489894

Cc1cc(-c2cnc3c(c2)c(Cc2cccc(Cl)c2)nn3COC(=O)C(C)(C)C)c(C)c(C(N)=O)c1NC(=O)N1CCOCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
AVPR1B P47901 3/20 0.33
AOC3 Q16853 2/20 0.33
NPY5R Q15761 1/20 0.32
NTRK1 P04629 1/20 0.32
STAT6 P42226 1/20 0.32
DYRK1B Q9Y463 1/20 0.31
SRC P12931 1/20 0.31
CTSS P25774 1/20 0.31
AURKA O14965 1/20 0.31
RPS6KB1 P23443 1/20 0.31
CSNK1D P48730 1/20 0.30
CSNK1E P49674 1/20 0.30
NPC1 O15118 1/20 0.30
PKM P14618 1/20 0.30
RAB9A P51151 1/20 0.30
THRB P10828 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3488948 0.80 KDM4E (0.35) KDM4EALDH1A1HPGDAVPR1BAOC3
SCHEMBL3489336 0.70 MAP4K1 (0.43) SRCPOLB
SCHEMBL13600201 0.66 ALDH1A1 (0.39) KDM4EALDH1A1HPGDAOC3NTRK1
SCHEMBL12344668 0.64 KDM4E (0.36) KDM4EALDH1A1HPGDAOC3NTRK1
SCHEMBL22479677 0.61 NTRK1 (0.49) KDM4EALDH1A1HPGDNTRK1NPC1
SCHEMBL12344670 0.60 NTRK1 (0.40) KDM4EALDH1A1HPGDAOC3NTRK1
SCHEMBL3489573 0.58 MAP4K1 (0.43)
SCHEMBL25596905 0.57 NPC1 (0.53) KDM4EALDH1A1NPC1RAB9AMEN1
SCHEMBL13600199 0.56 MAPK1 (0.41) SRC
SCHEMBL11197051 0.55 ALDH1A1 (0.76) KDM4EALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268994-B2 Fused ring heterocycle kinase modulators SGX PHARMACEUTICALS, INC. (US) 2012-09-18 US disclosed
US-20100036118-A1 Fused Ring Heterocycle Kinase Modulators SGX PHARMACEUTICALS, INC. 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036118-A1 Fused Ring Heterocycle Kinase Modulators MAP3K20, TTK, MAP3K19 KDM4E 832/4885ALDH1A1 4383/4885HPGD 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.